<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7482434\results\search\testTrace\results.xml">
  <result pre="effect of various potential disruptions to HIV prevention, testing, and" exact="treatment" post="services on HIV-related deaths and new infections in sub-Saharan"/>
  <result pre="the population of people living with HIV who are on" exact="treatment" post="would be expected to lead to a 1Â·63 times"/>
  <result pre="of other drugs such as co-trimoxazole, and suspension of HIV" exact="testing" post="would all have a substantial effect on population-level mortality"/>
  <result pre="make populations more susceptible to increases in HIV incidence, although" exact="physical distancing" post="measures could lead to reductions in risky sexual behaviour"/>
  <result pre="morbidity and mortality, clinic closures or reduced service availability, and" exact="physical distancing" post="and other measures put in place to combat the"/>
  <result pre="estimate the impact of different disruptions to HIV prevention and" exact="treatment" post="services as a result of the COVID-19 pandemic on"/>
  <result pre="condoms and ART) are varied to fit the model to" exact="prevalence" post="estimates from surveillance and surveys Epidemiological parameters (probability of"/>
  <result pre="(probability of transmission per sex act, variation by stage of" exact="infection" post="[informed by CD4 cell counts and viral load monitoring],"/>
  <result pre="[informed by CD4 cell counts and viral load monitoring], HIV" exact="testing" post="rate, mortality rate, presence of other ulcerative STIs or"/>
  <result pre="or suppressive ART) are varied to fit the model to" exact="prevalence" post="estimates from surveillance and surveys Parameters relating to population"/>
  <result pre="stage of infection), and the partnerships (sex acts per partner," exact="prevalence" post="of other STIs, type of sex, condom use) Acquisition"/>
  <result pre="load, and age Rate of progression through each stage of" exact="infection" post="is modelled on the basis of the mean duration"/>
  <result pre="initiates ART; new prognosis is calculated for ART dropouts HIV" exact="testing" post="and diagnosis Testing is by type of test and"/>
  <result pre="new prognosis is calculated for ART dropouts HIV testing and" exact="diagnosis" post="Testing is by type of test and population group"/>
  <result pre="on the basis of coverage level A person without a" exact="diagnosis" post="of HIV can be tested or not in each"/>
  <result pre="HIV can be tested or not in each 3-month period;" exact="testing" post="is indicated in antenatal clinics and for symptoms potentially"/>
  <result pre="antenatal clinics and for symptoms potentially of HIV, and general" exact="testing" post="with various degrees of targeting at people with higher"/>
  <result pre="various degrees of targeting at people with higher probability of" exact="infection" post="HIV testing and diagnosis is not explicitly represented but"/>
  <result pre="of targeting at people with higher probability of infection HIV" exact="testing" post="and diagnosis is not explicitly represented but is considered"/>
  <result pre="at people with higher probability of infection HIV testing and" exact="diagnosis" post="is not explicitly represented but is considered a prerequisite"/>
  <result pre="represented but is considered a prerequisite for any initiation of" exact="treatment" post="HIV testing and diagnosis occurs voluntarily, at antenatal visits,"/>
  <result pre="is considered a prerequisite for any initiation of treatment HIV" exact="testing" post="and diagnosis occurs voluntarily, at antenatal visits, or once"/>
  <result pre="a prerequisite for any initiation of treatment HIV testing and" exact="diagnosis" post="occurs voluntarily, at antenatal visits, or once symptomatic ART"/>
  <result pre="ART is determined by age, sex, CD4 cell count at" exact="treatment" post="initiation, and duration of treatment Risk of mortality while"/>
  <result pre="sex, CD4 cell count at treatment initiation, and duration of" exact="treatment" post="Risk of mortality while on ART is determined by"/>
  <result pre="by dynamically changing CD4 cell count over the course of" exact="treatment" post="Specific drugs and their current level of activity given"/>
  <result pre="ART is determined by age, sex, CD4 cell count at" exact="treatment" post="initiation, and duration of treatment ART interruption Immediate return"/>
  <result pre="sex, CD4 cell count at treatment initiation, and duration of" exact="treatment" post="ART interruption Immediate return to CD4 cell count at"/>
  <result pre="interruption Immediate return to CD4 cell count at time of" exact="treatment" post="initiation; survival progression is identical to those who are"/>
  <result pre="treatment initiation; survival progression is identical to those who are" exact="treatment" post="naive Substantial initial decrease in CD4 cell count towards"/>
  <result pre="services are broadly grouped as prevention programmes, HIV testing, and" exact="treatment" post="and care (table 2). At the end of the"/>
  <result pre="activity will be decreased during the disruption period due to" exact="physical distancing" post="measures (appendix pp 2â€&quot;7). Using the results on the"/>
  <result pre=".. .. 1Â·11 (1Â·00â€&quot;1Â·23) 1Â·04 (1Â·01â€&quot;1Â·07) .. .. .. HIV" exact="testing" post="Suspension of HIV testing 20% disruption 1Â·00 (1Â·00â€&quot;1Â·02) 1Â·01"/>
  <result pre="1Â·04 (1Â·01â€&quot;1Â·07) .. .. .. HIV testing Suspension of HIV" exact="testing" post="20% disruption 1Â·00 (1Â·00â€&quot;1Â·02) 1Â·01 (1Â·00â€&quot;1Â·02) 1Â·00 (0Â·99â€&quot;1Â·02)â€ .."/>
  <result pre="we assumed no new circumcisions would be done due to" exact="physical distancing" post="concerns due to the COVID-19 pandemic. For the HIV"/>
  <result pre="given region. The mortality rate for those on ART whose" exact="treatment" post="is suspended was applied on the basis of data"/>
  <result pre="ART drug resistance as a result of disruption of HIV" exact="treatment" post="and additional COVID-19-related deaths among people living with HIV"/>
  <result pre="start but might have progressed to a later stage of" exact="infection" post="before starting. Viral load testing, enhanced adherence counselling, and"/>
  <result pre="disruption period are unable to do so but might re-attempt" exact="testing" post="and ART initiation after the disruption period ends at"/>
  <result pre="Viral load suppression after ART initiation, including re-initiation after a" exact="treatment" post="interruption, is assumed to take an average of 3"/>
  <result pre="scenario are shown in the figure. Disruptions to care and" exact="treatment" post="services for people living with HIV are associated with"/>
  <result pre="to the supply of ART drugs to people already on" exact="treatment" post="resulting in discontinuation of ART. 6 months of such"/>
  <result pre="of other drugs such as co-trimoxazole, and suspension of HIV" exact="testing" post="would all have a substantial effect on population-level mortality,"/>
  <result pre="sex with non-regular partners also occurred as a result of" exact="physical distancing," post="then the net effect could be a reduction in"/>
  <result pre="make populations more susceptible to increases in HIV incidence, although" exact="physical distancing" post="measures could lead to reductions in risky sexual behaviour."/>
  <result pre="be particularly large, perhaps due to transmission during acute HIV" exact="infection" post="causing a synchronous wave of secondary spread, which might"/>
  <result pre="ART interruption, effects on prevention, testing, and other aspects of" exact="treatment" post="and care could be clinically significant. These programmes are"/>
  <result pre="For example, reductions in peer support might result in suboptimal" exact="treatment" post="adherence and retention in care. Health-care provisions of all"/>
  <result pre="20192019Joint United Nations Programme on HIV/AIDSGenevahttps://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_en.pdf 5NyoniTOkumuMCOVID-19-compliant strategies for supporting" exact="treatment" post="adherence among people living with HIV in sub-Saharan AfricaAIDS"/>
  <result pre="pandemic. President's Emergency Plan for AIDS Reliefhttps://www.state.gov/wp-content/uploads/2020/07/07.29.2020-PEPFAR-Technical-Guidance-During-COVID.pdfJuly 29, 2020 22MannMDieroLKemboiEAntiretroviral" exact="treatment" post="interruptions induced by the Kenyan postelection crisis are associated"/>
  <result pre="the role of food insecurity in adherence to care and" exact="treatment" post="among adult and pediatric populations living with HIV and"/>
  <result pre="of frequency of clinic visits and medcation pick-up on antiretroviral" exact="treatment" post="outcomes: a systematic literature review and meta-analysisJ Int AIDS"/>
 </snippets>
</snippetsTree>
